\-\ Texto\\:\\ \ \(0\)\
\-\ tc\\-99m\\ mdp\\ bone\\ scan\\ demonstrates\\ diffusely\\ increased\\ uptake\\ in\\ the\\ axial\\ skeleton\\ as\\ well\\ as\\ parts\\ of\\ the\\ appendicular\\ skeleton\\.\\ \\ the\\ kidneys\\ and\\ soft\\ tissue\\ activity\\ are\\ not\\ visualized\\.\\ \\ these\\ findings\\ are\\ consistent\\ with\\ a\\ superscan\\,\\ secondary\\ to\\ diffuse\\ osteoblastic\\ metastatic\\ disease\\ in\\ a\\ patient\\ with\\ known\\ prostate\\ cancer\\.\ \(0\)\
\-\ superscan\\ \\-\\-\\ diffuse\\ osteoblastic\\ metastasis\\ \\-\\ prostate\\ cancer\\.\ \(0\)\
\-\ metabolic\\ and\\ myeloproliferative\\ disorders\ \(1\)\
\-\ 70\\ year\\ old\\ male\\ with\\ a\\ history\\ of\\ prostate\\ cancer\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ superscan\\:\\ 0\\.3994009143534803\ \(0\)\
\-\ prostate\\:\\ 0\\.3926934461405452\ \(0\)\
\-\ osteoblastic\\:\\ 0\\.30237703772863417\ \(0\)\
\-\ skeleton\\:\\ 0\\.29399369876488557\ \(0\)\
\-\ cancer\\:\\ 0\\.2700428129568084\ \(0\)\
\-\ myeloproliferative\\:\\ 0\\.20651593978077906\ \(0\)\
\-\ diffuse\\:\\ 0\\.16950179289496733\ \(0\)\
\-\ parts\\:\\ 0\\.16278641714509015\ \(0\)\
\-\ appendicular\\:\\ 0\\.15826012313076634\ \(0\)\
\-\ mdp\\:\\ 0\\.1553555486944322\ \(0\)\
\-\ diffusely\\:\\ 0\\.1256763123555206\ \(0\)\
\-\ metabolic\\:\\ 0\\.12251281705750176\ \(0\)\
\-\ disorders\\:\\ 0\\.11932086407073875\ \(0\)\
\-\ kidneys\\:\\ 0\\.11633221106467859\ \(0\)\
\-\ 70\\:\\ 0\\.11157811699685338\ \(0\)\
\-\ as\\:\\ 0\\.10858284836172438\ \(0\)\
\-\ visualized\\:\\ 0\\.10552869264033996\ \(0\)\
\-\ uptake\\:\\ 0\\.1039164364752682\ \(0\)\
\-\ are\\:\\ 0\\.10256064903747204\ \(0\)\
\-\ activity\\:\\ 0\\.09921908739991549\ \(0\)\
\-\ metastasis\\:\\ 0\\.09904925855058075\ \(0\)\
\-\ known\\:\\ 0\\.08749507065680298\ \(0\)\
\-\ the\\:\\ 0\\.08089730642657583\ \(0\)\
\-\ scan\\:\\ 0\\.08017837603209169\ \(0\)\
\-\ secondary\\:\\ 0\\.0801021990435297\ \(0\)\
\-\ with\\:\\ 0\\.07938760591734306\ \(0\)\
\-\ axial\\:\\ 0\\.07806300350475248\ \(0\)\
\-\ these\\:\\ 0\\.076314787663308\ \(0\)\
\-\ metastatic\\:\\ 0\\.07411874477441957\ \(0\)\
\-\ bone\\:\\ 0\\.07373780484227004\ \(0\)\
\-\ consistent\\:\\ 0\\.073277211515379\ \(0\)\
\-\ increased\\:\\ 0\\.07307848397358797\ \(0\)\
\-\ soft\\:\\ 0\\.07194683968093604\ \(0\)\
\-\ tissue\\:\\ 0\\.07089256014236268\ \(0\)\
\-\ demonstrates\\:\\ 0\\.06789397947663635\ \(0\)\
\-\ in\\:\\ 0\\.06723799454881937\ \(0\)\
\-\ findings\\:\\ 0\\.0666981038911241\ \(0\)\
\-\ well\\:\\ 0\\.06543652690013335\ \(0\)\
\-\ male\\:\\ 0\\.06017051299224315\ \(0\)\
\-\ disease\\:\\ 0\\.056727901067146674\ \(0\)\
\-\ and\\:\\ 0\\.055850968551036384\ \(0\)\
\-\ not\\:\\ 0\\.05335093194981832\ \(0\)\
\-\ of\\:\\ 0\\.05289346677776615\ \(0\)\
\-\ history\\:\\ 0\\.05163214976967034\ \(0\)\
\-\ patient\\:\\ 0\\.043954978381902494\ \(0\)\
\-\ year\\:\\ 0\\.04164817006815755\ \(0\)\
\-\ old\\:\\ 0\\.03999666013727773\ \(0\)\
\-\ to\\:\\ 0\\.03378528839391279\ \(0\)\
